» Articles » PMID: 39642942

Stem Loop Mediated Transgene Modulation in Human T Cells

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Controlling gene expression is useful for many applications, but current methods often require external user inputs, such as the addition of a drug. We present an alternative approach using cell-autonomous triggers based on RNA stem loop structures in the 3' untranslated regions (UTRs) of mRNA. These stem loops are targeted by the RNA binding proteins Regnase-1 and Roquin-1, allowing us to program stimulation-induced transgene regulation in primary human T cells. By incorporating engineered stem loops into the 3' UTRs of transgenes, we achieved transgene repression through Regnase-1 and Roquin-1 activity, dynamic upregulation upon stimulation, and orthogonal tunability. To demonstrate the utility of this system, we employed it to modulate payloads in CAR-T cells. Our findings highlight the potential of leveraging endogenous regulatory machinery in T cells for transgene regulation and suggest RNA structure as a valuable layer for regulatory modulation.

References
1.
Maude S, Laetsch T, Buechner J, Rives S, Boyer M, Bittencourt H . Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. N Engl J Med. 2018; 378(5):439-448. PMC: 5996391. DOI: 10.1056/NEJMoa1709866. View

2.
Maude S, Frey N, Shaw P, Aplenc R, Barrett D, Bunin N . Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014; 371(16):1507-17. PMC: 4267531. DOI: 10.1056/NEJMoa1407222. View

3.
Zheng W, Wei J, Zebley C, Jones L, Dhungana Y, Wang Y . Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL. Blood. 2021; 138(2):122-135. PMC: 8288655. DOI: 10.1182/blood.2020009309. View

4.
Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J . Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016; 167(2):419-432.e16. PMC: 5072533. DOI: 10.1016/j.cell.2016.09.011. View

5.
Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C . Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019; 576(7787):471-476. PMC: 6937596. DOI: 10.1038/s41586-019-1821-z. View